64Cu-PSMA I&T

N/A

Report date: 2025/09/08 16:21:24

Base Information

Drug Name64Cu-PSMA I&T
Drug Alias NameCu-64-PSMA-I&T64-Copper-PSMA-I&TCopper-64-prostate specific membrane antigen I&TCopper Cu 64 PSMA I&T
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Copper > 64Cu
Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsPositron-emission tomography enhancers
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCurium Us Llc
China Registration ClassN/A

Develop Information

Active CompaniesPDRadiopharma IncPeptiDream IncCurium Us Llc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A